Anti hypertensive drug uses according to condition and age
"Hypertension"[MeSH Terms] AND antihypertensive agents
2024 ESC hypertension guidelines age 80 drug treatment first line conditions comorbidities
https://www.escardio.org/communities/councils/cardiology-pra…
| Age / clinical situation | Usual preferred approach | Important precautions |
|---|---|---|
| Children and adolescents | ACE inhibitor, ARB, long-acting CCB, or thiazide, selected with a pediatric specialist | Look for secondary hypertension, especially renal disease. Dose by weight. |
| Adults <55 years | Often ACE inhibitor or ARB is suitable, especially if renin-angiotensin system blockade is indicated | Do not combine ACE inhibitor + ARB. Check creatinine and potassium after starting or increasing dose. |
| Adults ≥55 years | Long-acting dihydropyridine CCB such as amlodipine is commonly useful; thiazide-like diuretic is another option | CCBs can cause ankle edema; thiazides can cause low sodium, low potassium, gout. |
| Older adult, fit | Same major drug classes can be used, but start low and titrate gradually | Measure seated and standing BP, review interacting drugs, renal function, electrolytes, falls risk. |
| Age >80 years or frailty | Usually begin with one low-dose agent rather than immediate multi-drug therapy, then individualize | Avoid overtreatment, symptomatic hypotension, dizziness, falls, and acute kidney injury. ESC material suggests a systolic target around 130-140 mmHg if tolerated and monotherapy initially in very old/frail people. ESC older-adult guidance |
| Condition | Preferred drug(s) | Why / key notes |
|---|---|---|
| Diabetes with albuminuria or diabetic kidney disease | ACE inhibitor or ARB | Reduces intraglomerular pressure and slows kidney disease progression. For type 1 diabetes with hypertension and albuminuria, ACE inhibitors are preferred; in type 2 diabetes with microalbuminuria, ACE inhibitor or ARB is appropriate. Brenner and Rector’s The Kidney; Textbook of Family Medicine 9e. |
| Chronic kidney disease with albuminuria | ACE inhibitor or ARB | Kidney-protective when albuminuria is present. Monitor potassium and creatinine. Avoid ACE inhibitor plus ARB. |
| CKD without albuminuria | ACE inhibitor, ARB, CCB, or diuretic based on eGFR and volume status | Loop diuretic may replace thiazide when kidney function is markedly reduced or there is fluid overload. |
| Heart failure with reduced ejection fraction (HFrEF) | Evidence-based beta-blocker such as carvedilol, bisoprolol, or metoprolol succinate; ACE inhibitor/ARB or ARNI; mineralocorticoid antagonist and SGLT2 inhibitor when indicated | These are chosen primarily to improve heart-failure outcomes, with BP lowering as an added effect. Avoid verapamil and diltiazem in HFrEF. |
| Previous myocardial infarction / angina / coronary artery disease | Beta-blocker plus ACE inhibitor or ARB when indicated | Beta-blocker helps angina and post-MI cardiac protection. A cardioselective beta-blocker is commonly selected for angina with hypertension. |
| Atrial fibrillation or tachyarrhythmia | Beta-blocker or rate-limiting CCB, diltiazem/verapamil, if no HFrEF | Controls ventricular rate and lowers BP. Avoid non-dihydropyridine CCBs in HFrEF. |
| Prior stroke or TIA | Any effective BP-lowering regimen, often ACE inhibitor/ARB + thiazide-like diuretic | Long-term BP control reduces recurrent stroke risk. A 2025 systematic review supports antihypertensive treatment for secondary-stroke prevention (PMID: 39780283). |
| Isolated systolic hypertension in older adults | Long-acting CCB or thiazide-like diuretic | Common in older age. Titrate carefully and assess orthostatic BP. |
| Pregnancy, chronic hypertension | Labetalol, extended-release nifedipine, or methyldopa | Contraindicated: ACE inhibitors, ARBs, and direct renin inhibitors. Labetalol or methyldopa are traditional choices; nifedipine is widely used. |
| Severe hypertension in pregnancy | IV labetalol, IV hydralazine, or oral immediate-release nifedipine in monitored care | Requires urgent obstetric assessment for pre-eclampsia and maternal-fetal risk. |
| Asthma or significant COPD | Prefer ACE inhibitor, ARB, CCB, or diuretic when possible | Avoid nonselective beta-blockers. A cardioselective beta-blocker may sometimes be used if there is a strong cardiac indication. |
| Gout / hyperuricemia | Losartan or CCB may be useful | Avoid or minimize thiazide and loop diuretics if they worsen uric acid or provoke gout. |
| Benign prostatic hyperplasia | Alpha-1 blocker such as doxazosin can improve urinary symptoms, but is not routine first-line BP monotherapy | Risk of postural hypotension, especially in older people. |
| Migraine with hypertension | Beta-blocker, such as propranolol or metoprolol, when otherwise appropriate | May help migraine prevention. Avoid if asthma, bradycardia, or heart block. |
| Essential tremor | Propranolol, if appropriate | Can treat tremor and lower BP, but not usually selected solely as first-line hypertension therapy. |
| Pheochromocytoma | Alpha-blockade first: phenoxybenzamine or doxazosin; beta-blocker only after adequate alpha blockade | Giving beta-blocker first can cause dangerous unopposed alpha-mediated vasoconstriction. |
| Aortic dissection or acute aortic syndrome | IV beta-blocker first, commonly labetalol or esmolol, in emergency care | Lowers heart rate and shear stress. Requires ICU-level emergency management. |
ABCD antihypertensive drugs uses as per age and indication of combinations drugs
"Hypertension"[MeSH Terms] AND "Antihypertensive Agents"[MeSH Terms]
NICE hypertension adults treatment age under 55 55 ACE inhibitor CCB step 2 combination recommendations
| Letter | Drug class | Examples | Main use |
|---|---|---|---|
| A | ACE inhibitor or ARB | Ramipril, enalapril, lisinopril; losartan, telmisartan | Younger patients, diabetes with albuminuria, CKD with proteinuria, heart failure, post-MI |
| B | Beta-blocker | Bisoprolol, metoprolol, carvedilol, atenolol | Not routine first-line uncomplicated HTN. Use when angina, post-MI, heart failure, AF/tachycardia, pregnancy with labetalol |
| C | Calcium-channel blocker | Amlodipine, nifedipine | Older patients, isolated systolic HTN, Black African/African-Caribbean patients |
| D | Diuretic | Indapamide, chlorthalidone, hydrochlorothiazide | Older patients, salt-sensitive HTN, edema or volume overload; useful as an add-on drug |
| Condition | Preferred class or combination | Avoid / caution |
|---|---|---|
| Diabetes with albuminuria | A: ACEi or ARB | Do not combine ACEi + ARB |
| CKD with proteinuria | A: ACEi or ARB | Monitor creatinine and K+ |
| Heart failure with reduced EF | ACEi/ARB or ARNI + evidence-based B such as carvedilol, bisoprolol, or metoprolol succinate; diuretic for congestion | Avoid verapamil/diltiazem in HFrEF |
| Post-MI / angina | A + B is often appropriate | Avoid beta-blocker in marked bradycardia or heart block |
| Atrial fibrillation with rapid rate | B or rate-limiting CCB, diltiazem/verapamil, if no HFrEF | Avoid diltiazem/verapamil in HFrEF |
| Isolated systolic HTN in elderly | C or D | Start low, monitor postural hypotension |
| Black African / African-Caribbean origin, without diabetes | C first; add ARB if required | ACEi monotherapy may be less effective |
| Pregnancy | Labetalol, modified-release nifedipine, or methyldopa | No ACEi or ARB |
| Asthma | Prefer A, C, or D | Avoid nonselective beta-blockers |
| Gout | A or C, with losartan sometimes useful | Avoid thiazide/loop diuretics if they worsen gout |
| BPH | Alpha-blocker can relieve urinary symptoms, but not preferred as routine BP monotherapy | Orthostatic hypotension, especially in older people |
A + C + D
ABCD regimen: A = ACE inhibitor/ARB, B = beta-blocker, C = calcium-channel blocker, D = thiazide-like diuretic. In people under 55 years, begin with A; in people 55 years or older, begin with C or D; use A + C or A + D as dual therapy, then A + C + D as triple therapy. Beta-blockers are mainly used when there is a compelling cardiac indication, such as angina, post-MI state, heart failure, or tachyarrhythmia.